Physician profile
Ma Luo
NPI 1518301332
$22,575.80
in general payments reported to CMS, 2019-2025
44 companies · $966 in 2025
The $966 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,820 · 2020: $2,200 · 2021: $1,954 · 2022: $4,747 · 2023: $6,400 · 2024: $1,490 · 2025: $966.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,783 · Travel and Lodging: $3,073.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,783.11 |
| Travel and Lodging | $3,072.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $7,949.30 | 2019-2024 | Senza |
| Abbott Laboratories | $6,634.65 | 2019-2025 | Proclaim, Eterna, Octrode |
| Vertiflex, INC. | $1,459.29 | 2019 | |
| Boston Scientific Corporation | $841.23 | 2019-2025 | Intracept |
| Pacira Pharmaceuticals Incorporated | $557.25 | 2022-2023 | Iovera |
| Si-Bone, INC. | $453.10 | 2019-2024 | |
| Abbvie INC. | $431.90 | 2021-2025 | |
| Collegium Pharmaceutical, INC. | $406.95 | 2019-2024 | Belbuca, Nucynta, Xtampza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $396.18 | 2019-2025 | Relistor |
| Globus Medical, INC. | $355.80 | 2025 | Senza |
| Medtronic USA, INC. | $339.74 | 2019 | |
| Allergan, INC. | $252.87 | 2020-2022 | |
| Lundbeck LLC | $246.27 | 2021-2024 | Vyepti |
| Relievant Medsystems, INC. | $231.12 | 2022-2023 | Intracept |
| Arbor Pharmaceuticals, INC. | $192.18 | 2019-2022 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ma Luo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.